Literature DB >> 9382467

Autosomal dominant dementia with widespread neurofibrillary tangles.

L A Reed1, T J Grabowski, M L Schmidt, J C Morris, A Goate, A Solodkin, G W Van Hoesen, R L Schelper, C J Talbot, M A Wragg, J Q Trojanowski.   

Abstract

Several familial dementing conditions with atypical features have been characterized, but only rarely is the neuropathology dominated solely by neurofibrillary lesions. We present a Midwestern American pedigree spanning four generations in which 15 individuals were affected by early-onset dementia with long disease duration, with an autosomal dominant inheritance pattern, and with tau-rich neurofibrillary pathology found in the brain post mortem. The average age at presentation was 55 years with gradual onset and progression of memory loss and personality change. After 30 years' disease duration, the proband's neuropathologic examination demonstrated abundant intraneuronal neurofibrillary tangles (NFTs) involving the hippocampus, pallidum, subthalamic nucleus, substantia nigra, pons, and medulla. Only sparse neocortical tangles were present and amyloid plaques were absent. The tangles were recognized by antibodies specific for phosphorylation-independent (Tau-2, T46, 133, and Alz-50) and phosphorylation-dependent epitopes (AT8, T3P, PHF-1, 12E8, AT6, AT18, AT30) in tau proteins. Electron microscopy of NFTs in the dentate gyrus and midbrain demonstrated paired helical filaments. Although the clinical phenotype resembles Alzheimer's disease, and the neuropathologic phenotype resembles progressive supranuclear palsy, an alternative consideration is that this familial disorder may be a new or distinct disease entity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9382467     DOI: 10.1002/ana.410420406

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  47 in total

1.  Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).

Authors:  N Matsumura; T Yamazaki; Y Ihara
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

Review 2.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

Review 3.  New approaches to genetic counseling and testing for Alzheimer's disease and frontotemporal degeneration.

Authors:  Jill S Goldman
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

4.  Familial frontotemporal dementia associated with the novel MAPT mutation T427M.

Authors:  Giorgio Giaccone; Giacomina Rossi; Laura Farina; Gabriella Marcon; Giuseppe Di Fede; Marcella Catania; Michela Morbin; Leonardo Sacco; Orso Bugiani; Fabrizio Tagliavini
Journal:  J Neurol       Date:  2005-06-06       Impact factor: 4.849

Review 5.  The tauopathies: toward an experimental animal model.

Authors:  M Goedert; M Hasegawa
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

Review 6.  Three dimensions of the amyloid hypothesis: time, space and 'wingmen'.

Authors:  Erik S Musiek; David M Holtzman
Journal:  Nat Neurosci       Date:  2015-06       Impact factor: 24.884

7.  C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic.

Authors:  Aleksandra Wojtas; Kristin A Heggeli; Nicole Finch; Matt Baker; Mariely Dejesus-Hernandez; Steven G Younkin; Dennis W Dickson; Neill R Graff-Radford; Rosa Rademakers
Journal:  Am J Neurodegener Dis       Date:  2012-05-16

8.  FTDP-17 with Pick body-like inclusions associated with a novel tau mutation, p.E372G.

Authors:  Pawel Tacik; Michael A DeTure; Yari Carlomagno; Wen-Lang Lin; Melissa E Murray; Matthew C Baker; Keith A Josephs; Bradley F Boeve; Zbigniew K Wszolek; Neill R Graff-Radford; Joseph E Parisi; Leonard Petrucelli; Rosa Rademakers; Richard S Isaacson; Kenneth M Heilman; Ronald C Petersen; Dennis W Dickson; Naomi Kouri
Journal:  Brain Pathol       Date:  2016-10-05       Impact factor: 6.508

9.  C9orf72 hexanucleotide repeat expansions in clinical Alzheimer disease.

Authors:  Matthew Harms; Bruno A Benitez; Nigel Cairns; Breanna Cooper; Paul Cooper; Kevin Mayo; David Carrell; Kelley Faber; Jennifer Williamson; Tom Bird; Ramon Diaz-Arrastia; Tatiana M Foroud; Bradley F Boeve; Neill R Graff-Radford; Richard Mayeux; Sumitra Chakraverty; Alison M Goate; Carlos Cruchaga
Journal:  JAMA Neurol       Date:  2013-06       Impact factor: 18.302

10.  Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.

Authors:  Marwa Aboukhatwa; Laura Dosanjh; Yuan Luo
Journal:  Mol Neurodegener       Date:  2010-03-12       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.